Literature DB >> 11956437

Long-term voiding pattern of patients with ileal orthotopic bladder substitutes.

Stephan Madersbacher1, Karin Möhrle, Fiona Burkhard, Urs E Studer.   

Abstract

PURPOSE: Good long-term functional outcome of orthotopic bladder substitution will ultimately decide whether it is here to stay. Therefore, we analyzed exclusively voiding patterns of long-term survivors with an orthotopic ileal bladder substitute.
MATERIALS AND METHODS: In all patients with an ileal orthotopic bladder substitute day and nighttime continence status, voiding frequency, bladder capacity and pad usage were prospectively assessed by frequency volume charts and a standardized questionnaire. All men surviving 5 or more years with a median followup of 95 months (range 60-132) were evaluated.
RESULTS: Spontaneous voiding was possible in 82 of 86 (95.3%) evaluable patients after catheter removal. Daytime continence increased from 61% after 3 months to 92% at 12 months and remained stable throughout the following 4 years yet decreased slightly thereafter. Nocturnal continence rates were 10% to 15% lower throughout the study period. Functional reservoir capacity averaged 473 ml. after 12 months and did not change in subsequent years. After a decrease during the first 12 months, daytime frequency (4.1 to 4.8 times daily) and nocturia (1.8 to 2.3 a night) did not change in the next decade. Patient age at surgery was an important determinant for long-term reservoir capacity, nocturia and continence status.
CONCLUSIONS: These data provide evidence for good long-term functional outcome following orthotopic ileal bladder substitution up to 11 years. We attribute the sustained ability to void to the relatively small reservoir size, which is made of 40 to 44 cm. of ileum, the avoidance of any funnel shaped outlet but rather a side-to-end intestine-urethral anastomosis as well as lifelong meticulous followup.

Entities:  

Mesh:

Year:  2002        PMID: 11956437

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  32 in total

1.  [Tips and tricks for nerve-sparing cystectomy].

Authors:  S Madersbacher; W Hochreiter; U E Studer
Journal:  Urologe A       Date:  2004-02       Impact factor: 0.639

2.  Caveats when interpreting intravenous urograms following ileal orthotopic bladder substitution.

Authors:  Harriet C Thoeny; Urs E Studer; Stephan Madersbacher; Martin J Sonnenschein; Peter Vock
Journal:  Eur Radiol       Date:  2004-02-17       Impact factor: 5.315

3.  Functional outcomes after urinary diversion: The importance of long-term assessment.

Authors:  Keith Rourke
Journal:  Can Urol Assoc J       Date:  2010-10       Impact factor: 1.862

Review 4.  [Advanced bladder cancer in elderly patients. Prognostic outcomes and therapeutic strategies].

Authors:  M Rink; F K Chun; T F Chromecki; H Fajkovic; R Dahlem; M Fisch; S F Shariat
Journal:  Urologe A       Date:  2012-06       Impact factor: 0.639

5.  Surgery: preserving continence in muscle-invasive bladder cancer.

Authors:  Anthony Costello; Rajiv Goel
Journal:  Nat Rev Clin Oncol       Date:  2009-04       Impact factor: 66.675

6.  The perioperative and convalescence nursing of 5 cases of Monti ileovesicostomy.

Authors:  Li Ma; Ling Liu; Hong Shen; Dan Dan; Li Wang; Yu-Han Deng
Journal:  Int J Clin Exp Med       Date:  2015-02-15

7.  The case for prostate capsule-sparing radical cystectomy in selected patients.

Authors:  Laurence Klotz; Jehonathan Pinthus
Journal:  Can Urol Assoc J       Date:  2009-12       Impact factor: 1.862

Review 8.  Bladder cancer in the elderly.

Authors:  Shahrokh F Shariat; Matthew Milowsky; Michael J Droller
Journal:  Urol Oncol       Date:  2009 Nov-Dec       Impact factor: 3.498

9.  Prostate capsule sparing radical cystectomy: oncologic safety and clinical outcome.

Authors:  Laurence Klotz
Journal:  Ther Adv Urol       Date:  2009-04

Review 10.  Ileal conduit: standard urinary diversion for elderly patients undergoing radical cystectomy.

Authors:  Khurram M Siddiqui; Jonathan I Izawa
Journal:  World J Urol       Date:  2015-10-16       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.